"WE TREAT CIVILIANS AND MILITARY! Conditions we treat include: • Partial thickness burns greater than 10% total body surface area (TBSA). • Burns that involve the face, hands, feet, genitalia, perineum, or major joints. • Third degree burns of any size. • Electrical burns, including lightning injury. • Inhalation injury. • TENS / SJS / Desquamating skin disease / Staphylococcal scalded skin syndrome (SSSS) • Necrotizing soft tissue infection that may require reconstruction and skin grafting. • Burn injury or necrotizing soft tissue infections in patients with preexisting medical disorders that could complicate management, prolong recovery, or affect mortality. • Any adult patient with burns and concomitant trauma."

During the past decade, US Army Institute of Surgical Research conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 8 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "US Army Institute of Surgical Research" #1 sponsor was "United States Army Institute of Surgical Research" with 16 trials, followed by "American Burn Association" with 3 trials sponsored, "Avita Medical" with 3 trials sponsored, "Stratatech, a Mallinckrodt Company" with 3 trials sponsored and "Neodyne Biosciences, Inc." with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "US Army Institute of Surgical Research" #1 collaborator was "U.S. Army Medical Research and Development Command" with 2 trials as a collaborator, "United States Army Institute of Surgical Research" with 2 trials as a collaborator, "United States Department of Defense" with 2 trials as a collaborator, "BioStat International, Inc." with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "US Army Institute of Surgical Research" are "Burns" (17 trials), "Skin Wound" (2 trials), "Trauma-related Wound" (2 trials), "Burn Injury" (1 trials) and "Burn Scar" (1 trials). Many other conditions were trialed in "US Army Institute of Surgical Research" in a lesser frequency.

Most popular intervention types in "US Army Institute of Surgical Research" are "Device" (13 trials), "Procedure" (7 trials), "Other" (5 trials), "Biological" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "StrataGraft Skin Tissue" (3 trials), "Autograft" (2 trials), "Alpha Stim 100 (Cranial Electrotherapy Stimulation)" (1 trials), "An FDA approved continuous renal replacement device" (1 trials) and "Blood Draw" (1 trials). Other intervention names were less common.

The vast majority of trials in "US Army Institute of Surgical Research" are 29 trials for "All" genders.

Currently, there are NaN active trials in "US Army Institute of Surgical Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in US Army Institute of Surgical Research, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in US Army Institute of Surgical Research, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 20 trials that are defined as “Not Applicable".